Patents by Inventor Kai Gao

Kai Gao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aralkyl alcohol pyridine derivative compounds and the use thereof as medicaments for treating depression
    Patent number: 8618133
    Abstract: The present invention relates to an aralkyl alcohol piperidine derivative and use as antidepressant thereof. The said aralkyl alcohol piperidine derivative has a triple inhibition effect on the reuptaking of 5-HT, NA and DA. The derivative may be administered to the patient in need of such treatment in the form of composition by oral administration, injection and the like.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: December 31, 2013
    Assignee: Jiangsu Hengyi Pharmaceutical Co., Ltd.
    Inventors: Jianqi Li, Kai Gao, Wangping Cai, Yongyong Zheng
  • Aralkyl alcohol piperidine derivative and the use thereof as a medicament for treating depression
    Publication number: 20110160247
    Abstract: The present invention relates to an aralkyl alcohol piperidine derivative and use as antidepressant thereo. The said aralkyl alcohol piperidine derivative has a triple inhibition effect on the reuptaking of 5-HT, NA and DA. The derivative may be administered to the patient in need of such treatment in the form of composition by oral administration, injection and the like.
    Type: Application
    Filed: June 8, 2009
    Publication date: June 30, 2011
    Applicants: JIANGSU GOWORTH INVESTMENT CO. LTD, SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY
    Inventors: Jianqi Li, Kai Gao, Wangping Cai, Yongyong Zheng
  • Aralkyl Substituted Piperidine or Piperazine Derivatives and Their Use for Treating Schizophrenia
    Publication number: 20110160199
    Abstract: The present invention discloses an aralkyl substituted piperidine or piperazine derivative and the use of the derivative in preparation of medicaments for treating schizophrenia and correlative psychoneuroses. It is shown by pharmacological tests that the derivative of the present invention has better antischizophrenic effect and less toxicity. Said derivative is a free base or salt of the compound having the following general formula.
    Type: Application
    Filed: July 28, 2008
    Publication date: June 30, 2011
    Applicants: JIANGSU GOWORTH INVESTMENT CO. LTD., SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY
    Inventors: Jianqi Li, Shaoping Peng, Wangping Cai, Kai Gao
  • BENZOTHIOPHENE ALKANOL PIPERAZINE DERIVATIVES AND THEIR USE AS ANTIDEPRESSANT
    Publication number: 20110118263
    Abstract: The invention discloses benzothiophene alkanol piperazine derivatives and their use as antidepressants. The invention discloses the said benzothiophene alkanol piperazine derivative having triple inhibition effect on the reuptake of 5-HT, NA and DA. Compared with clinical used antidepressants so far having single target, e.g. desipramine and fluoxetine, and clinical used antidepressants so far having double targets, e.g venlafaxine and duloxetine, the said benzothiophene alkanol piperazine derivatives of the present invention may have a broader indication range and less toxic and side effects to nervous system. The benzothiophene alkanol piperazine derivatives are the compounds with the following formula or their pharmaceutically acceptable salts, wherein Ar1, R1-R4, X, Y, m and n have the same definition as defined in claim 1.
    Type: Application
    Filed: June 30, 2009
    Publication date: May 19, 2011
    Applicant: CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd.
    Inventors: Jianqi Li, Kai Gao, Na Lv